How Much MOTS-c Should You Take? A Practical Dosing Guide
Quick Answer
The short version: MOTS-c is dosed via subcutaneous injection in research, typically varies. No established human dosing.
MOTS-c at a glance:
- Drug class: Mitochondrial-derived peptide
- Route: subcutaneous injection in research
- Typical frequency: varies
- Half-life: minutes systemically
Dosing MOTS-c correctly isn't complicated, but the details matter. The standard schedule is varies via subcutaneous injection in research, and the key decisions happen during titration.
Standard Dosing Schedule for MOTS-c
No established human dosing.
The typical schedule for MOTS-c is varies via subcutaneous injection in research. Half-life of minutes systemically explains why this schedule works — the drug stays active long enough to support that interval.
Titration: Why Starting Low Matters
For this class of compound, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms .
A typical titration plan for MOTS-c holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.
Missed Doses
If a dose of MOTS-c is missed: for daily schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (minutes systemically) and the specific product label. Never double up to make up for a missed dose.
Dose Adjustments
Dose adjustments may be needed for the following:
- Significant weight loss or weight gain
- Side-effect intolerance at the current step
- Changes in renal or hepatic function
- Drug interactions (particularly relevant for any concurrent medications)
We cover the side-effect side of dose decisions in MOTS-c side effects and the cost angle of dose escalation in MOTS-c cost.
What the Trials Used
Published trial data for MOTS-c comes primarily from: Lee et al. 2015, Cell Metabolism — original characterization of MOTS-c metabolic effects.
That data drives the labeled dosing range, which is what physicians prescribe by.
Sponsored — Affiliate Disclosure
Ready to Start Your GLP-1 Journey?
Special Populations
The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.
For MOTS-c: the standard contraindications for this drug class apply.
Bottom Line
The single biggest dosing mistake we see with MOTS-c is impatience — skipping titration steps to get to the goal dose faster. It almost always backfires.
Frequently Asked Questions
Frequently Asked Questions
Related Reading
- What Is MOTS-c? Everything You Should Know Before Starting
- What Nobody Tells You About MOTS-c Side Effects
- MOTS-c Outcomes Decoded: Who Responds Best and Why
- How Much Does MOTS-c Really Cost? The Honest Breakdown
- NAD+ 101: A Plain-English Guide for 2026
- NAD+ Side Effects Decoded: What's Normal vs. What Isn't
Sources
- Birk AV et al. The Mitochondrial-Targeted Peptide SS-31 Selectively Improves Mitochondrial Function. JASN 2013;24:1250.
- Lee C et al. The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis. Cell Metabolism 2015;21:443.
This page is informational only and is not medical advice. We do not provide guidance for self-administration of compounds that are not FDA-approved.
Related Articles
- →What Is MOTS-c? Everything You Should Know Before Starting
- →What Nobody Tells You About MOTS-c Side Effects
- →MOTS-c Outcomes Decoded: Who Responds Best and Why
- →How Much Does MOTS-c Really Cost? The Honest Breakdown
- →NAD+ 101: A Plain-English Guide for 2026
- →NAD+ Side Effects Decoded: What's Normal vs. What Isn't
